c-MET, a proto-oncogene tyrosine kinase receptor, is overexpressed in SCCHN, and its ligand, hepatocyte growth factor (HGF), stimulates cell proliferation, motility and invasion [25]. This evidence concerns the gene MET and head and neck squamous cell carcinoma.